Tim Lahm
Concepts (477)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Hypertension, Pulmonary | 59 | 2026 | 1957 | 9.580 |
Why?
| | Ventricular Dysfunction, Right | 23 | 2026 | 248 | 6.650 |
Why?
| | Ventricular Function, Right | 21 | 2026 | 300 | 5.290 |
Why?
| | Pulmonary Artery | 26 | 2026 | 1116 | 3.340 |
Why?
| | Estrogen Receptor alpha | 7 | 2026 | 154 | 3.100 |
Why?
| | Hypoxia | 19 | 2025 | 1211 | 2.440 |
Why?
| | Hypertrophy, Right Ventricular | 10 | 2026 | 151 | 2.420 |
Why?
| | Estradiol | 9 | 2026 | 517 | 2.270 |
Why?
| | Endothelial Cells | 12 | 2026 | 876 | 2.240 |
Why?
| | Estrogens | 11 | 2023 | 364 | 1.830 |
Why?
| | Rats, Sprague-Dawley | 31 | 2026 | 2537 | 1.390 |
Why?
| | Heart Ventricles | 10 | 2026 | 762 | 1.380 |
Why?
| | Bone Morphogenetic Protein Receptors, Type II | 3 | 2021 | 51 | 1.370 |
Why?
| | Pulmonary Embolism | 4 | 2023 | 246 | 1.330 |
Why?
| | Ventricular Remodeling | 8 | 2026 | 283 | 1.280 |
Why?
| | Gonadal Steroid Hormones | 8 | 2026 | 143 | 1.250 |
Why?
| | Estrogen Receptor beta | 3 | 2018 | 40 | 1.240 |
Why?
| | Heart Failure | 9 | 2026 | 2329 | 1.220 |
Why?
| | Familial Primary Pulmonary Hypertension | 10 | 2023 | 194 | 1.220 |
Why?
| | Vasoconstriction | 8 | 2008 | 216 | 1.210 |
Why?
| | Sex Characteristics | 10 | 2022 | 801 | 1.110 |
Why?
| | Rats | 30 | 2026 | 5586 | 1.110 |
Why?
| | Receptors, Estrogen | 4 | 2023 | 406 | 1.070 |
Why?
| | Animals | 71 | 2026 | 38107 | 1.050 |
Why?
| | Nitric Oxide | 5 | 2021 | 883 | 1.050 |
Why?
| | Lung | 13 | 2025 | 4122 | 1.030 |
Why?
| | Ventricular Function, Left | 5 | 2019 | 541 | 0.970 |
Why?
| | Adaptation, Physiological | 4 | 2024 | 568 | 0.930 |
Why?
| | Apelin | 3 | 2021 | 10 | 0.910 |
Why?
| | Lung Diseases | 5 | 2025 | 787 | 0.910 |
Why?
| | Neovascularization, Physiologic | 2 | 2026 | 189 | 0.880 |
Why?
| | Sex Factors | 13 | 2026 | 2107 | 0.870 |
Why?
| | Disease Models, Animal | 21 | 2026 | 4580 | 0.870 |
Why?
| | Heart | 5 | 2020 | 626 | 0.850 |
Why?
| | Male | 66 | 2026 | 73396 | 0.790 |
Why?
| | Humans | 88 | 2026 | 146342 | 0.740 |
Why?
| | Health Status Disparities | 1 | 2026 | 322 | 0.740 |
Why?
| | Hypoxia-Inducible Factor 1, alpha Subunit | 3 | 2018 | 299 | 0.670 |
Why?
| | Vascular Endothelial Growth Factor A | 11 | 2024 | 545 | 0.650 |
Why?
| | Veterans | 6 | 2020 | 1650 | 0.630 |
Why?
| | Ventricular Pressure | 7 | 2022 | 52 | 0.620 |
Why?
| | Stenosis, Pulmonary Artery | 1 | 2020 | 4 | 0.620 |
Why?
| | Renin-Angiotensin System | 1 | 2020 | 80 | 0.620 |
Why?
| | Angiotensin Receptor Antagonists | 1 | 2020 | 115 | 0.610 |
Why?
| | Mineralocorticoid Receptor Antagonists | 1 | 2020 | 69 | 0.600 |
Why?
| | Angiotensin-Converting Enzyme Inhibitors | 1 | 2020 | 228 | 0.580 |
Why?
| | Iron | 2 | 2021 | 359 | 0.570 |
Why?
| | Cardiovascular System | 1 | 2020 | 137 | 0.570 |
Why?
| | Vascular Remodeling | 6 | 2025 | 208 | 0.560 |
Why?
| | Pulmonary Wedge Pressure | 2 | 2020 | 66 | 0.550 |
Why?
| | Telangiectasia, Hereditary Hemorrhagic | 1 | 2018 | 14 | 0.550 |
Why?
| | Hepatopulmonary Syndrome | 1 | 2018 | 23 | 0.550 |
Why?
| | Histamine H2 Antagonists | 1 | 2018 | 22 | 0.540 |
Why?
| | Neovascularization, Pathologic | 2 | 2017 | 287 | 0.540 |
Why?
| | Female | 49 | 2026 | 79499 | 0.540 |
Why?
| | Bronchodilator Agents | 2 | 2017 | 186 | 0.540 |
Why?
| | Lung Injury | 2 | 2015 | 263 | 0.530 |
Why?
| | Liver Diseases | 1 | 2021 | 304 | 0.520 |
Why?
| | Vascular Diseases | 1 | 2020 | 252 | 0.500 |
Why?
| | Up-Regulation | 4 | 2021 | 841 | 0.500 |
Why?
| | Myocardial Contraction | 3 | 2017 | 292 | 0.500 |
Why?
| | Oxygen Inhalation Therapy | 2 | 2017 | 190 | 0.500 |
Why?
| | Hyperoxia | 2 | 2015 | 126 | 0.480 |
Why?
| | Intention | 1 | 2018 | 187 | 0.480 |
Why?
| | Monocrotaline | 4 | 2026 | 34 | 0.470 |
Why?
| | High-Intensity Interval Training | 1 | 2016 | 45 | 0.470 |
Why?
| | Signal Transduction | 11 | 2026 | 5246 | 0.440 |
Why?
| | Research | 1 | 2018 | 421 | 0.430 |
Why?
| | Cell Hypoxia | 7 | 2018 | 249 | 0.430 |
Why?
| | Reperfusion Injury | 4 | 2011 | 300 | 0.430 |
Why?
| | Physical Conditioning, Animal | 3 | 2025 | 243 | 0.380 |
Why?
| | Hemodynamics | 7 | 2022 | 1114 | 0.380 |
Why?
| | Blood Pressure | 4 | 2015 | 1765 | 0.380 |
Why?
| | Hypertension | 2 | 2021 | 1272 | 0.360 |
Why?
| | Cardiac Resynchronization Therapy | 1 | 2012 | 63 | 0.350 |
Why?
| | Whipple Disease | 1 | 2011 | 7 | 0.350 |
Why?
| | Adenocarcinoma, Bronchiolo-Alveolar | 1 | 2011 | 20 | 0.340 |
Why?
| | Embolism, Air | 1 | 2011 | 14 | 0.340 |
Why?
| | Magnesium Sulfate | 1 | 2011 | 18 | 0.340 |
Why?
| | Pneumothorax | 1 | 2011 | 54 | 0.330 |
Why?
| | Pulmonary Medicine | 2 | 2024 | 78 | 0.320 |
Why?
| | HIV Infections | 1 | 2026 | 3215 | 0.320 |
Why?
| | Leukapheresis | 1 | 2010 | 27 | 0.320 |
Why?
| | Calcium Channel Blockers | 1 | 2011 | 165 | 0.310 |
Why?
| | Bradykinin | 1 | 2010 | 49 | 0.310 |
Why?
| | Pulmonary Circulation | 3 | 2023 | 431 | 0.310 |
Why?
| | Cells, Cultured | 8 | 2026 | 4118 | 0.300 |
Why?
| | Paracrine Communication | 6 | 2008 | 67 | 0.290 |
Why?
| | Sepsis | 3 | 2010 | 669 | 0.290 |
Why?
| | Leukocytes | 1 | 2010 | 301 | 0.280 |
Why?
| | Calcium | 2 | 2012 | 1181 | 0.280 |
Why?
| | Myocardium | 5 | 2020 | 948 | 0.280 |
Why?
| | Blastomycosis | 1 | 2008 | 11 | 0.270 |
Why?
| | Altitude | 2 | 2024 | 469 | 0.260 |
Why?
| | Apoptosis | 4 | 2026 | 2439 | 0.260 |
Why?
| | Aged | 14 | 2021 | 26432 | 0.260 |
Why?
| | Acute Lung Injury | 1 | 2011 | 312 | 0.260 |
Why?
| | Lab-On-A-Chip Devices | 2 | 2025 | 63 | 0.250 |
Why?
| | Fellowships and Scholarships | 2 | 2024 | 355 | 0.250 |
Why?
| | Biomedical Research | 2 | 2025 | 729 | 0.250 |
Why?
| | Endothelins | 1 | 2007 | 61 | 0.250 |
Why?
| | Stroke Volume | 3 | 2020 | 652 | 0.250 |
Why?
| | rhoA GTP-Binding Protein | 1 | 2007 | 76 | 0.250 |
Why?
| | Cardiotonic Agents | 2 | 2021 | 96 | 0.240 |
Why?
| | Administration, Inhalation | 2 | 2019 | 567 | 0.240 |
Why?
| | Vascular Resistance | 2 | 2020 | 365 | 0.240 |
Why?
| | Menstrual Cycle | 1 | 2007 | 145 | 0.240 |
Why?
| | Middle Aged | 15 | 2021 | 36619 | 0.230 |
Why?
| | Image Cytometry | 1 | 2025 | 13 | 0.230 |
Why?
| | Adult | 15 | 2024 | 41087 | 0.230 |
Why?
| | Adenosine Deaminase | 1 | 2025 | 45 | 0.220 |
Why?
| | Fruit and Vegetable Juices | 1 | 2025 | 23 | 0.220 |
Why?
| | Calcium Signaling | 1 | 2007 | 246 | 0.220 |
Why?
| | Survival Analysis | 2 | 2026 | 1378 | 0.220 |
Why?
| | Microfluidic Analytical Techniques | 1 | 2025 | 80 | 0.220 |
Why?
| | Adrenal Cortex Hormones | 1 | 2008 | 486 | 0.220 |
Why?
| | Nitrates | 1 | 2025 | 97 | 0.210 |
Why?
| | Rats, Mutant Strains | 2 | 2021 | 19 | 0.210 |
Why?
| | Propionates | 2 | 2018 | 39 | 0.210 |
Why?
| | Neoplasms | 1 | 2020 | 2954 | 0.200 |
Why?
| | Microtubules | 1 | 2026 | 226 | 0.200 |
Why?
| | Intracellular Signaling Peptides and Proteins | 1 | 2007 | 457 | 0.200 |
Why?
| | Myocardial Reperfusion Injury | 3 | 2010 | 140 | 0.200 |
Why?
| | United States | 13 | 2025 | 16136 | 0.200 |
Why?
| | Antihypertensive Agents | 2 | 2018 | 519 | 0.200 |
Why?
| | Mice | 15 | 2026 | 18297 | 0.200 |
Why?
| | Autophagy | 2 | 2016 | 290 | 0.200 |
Why?
| | Reproductive Health Services | 1 | 2023 | 23 | 0.190 |
Why?
| | Databases, Factual | 2 | 2020 | 1493 | 0.190 |
Why?
| | SOXF Transcription Factors | 2 | 2023 | 16 | 0.190 |
Why?
| | Nitriles | 2 | 2018 | 212 | 0.190 |
Why?
| | Chloride Channels | 1 | 2023 | 33 | 0.190 |
Why?
| | Double-Blind Method | 2 | 2019 | 2070 | 0.190 |
Why?
| | Myocytes, Cardiac | 3 | 2021 | 544 | 0.190 |
Why?
| | Stem Cell Transplantation | 3 | 2008 | 190 | 0.180 |
Why?
| | Echocardiography | 2 | 2017 | 645 | 0.180 |
Why?
| | United States Department of Veterans Affairs | 2 | 2017 | 777 | 0.180 |
Why?
| | Chlorides | 1 | 2023 | 138 | 0.180 |
Why?
| | Aged, 80 and over | 7 | 2021 | 8391 | 0.170 |
Why?
| | Cell Movement | 1 | 2026 | 951 | 0.170 |
Why?
| | Lung Neoplasms | 2 | 2014 | 2675 | 0.170 |
Why?
| | RNA-Binding Proteins | 1 | 2025 | 465 | 0.170 |
Why?
| | Intercellular Signaling Peptides and Proteins | 3 | 2015 | 372 | 0.170 |
Why?
| | Dehydroepiandrosterone Sulfate | 1 | 2021 | 43 | 0.170 |
Why?
| | Single-Cell Analysis | 1 | 2025 | 370 | 0.170 |
Why?
| | NLR Family, Pyrin Domain-Containing 3 Protein | 1 | 2022 | 167 | 0.170 |
Why?
| | Menopause, Premature | 1 | 2021 | 12 | 0.160 |
Why?
| | Societies, Medical | 3 | 2025 | 907 | 0.160 |
Why?
| | Atrial Pressure | 1 | 2020 | 2 | 0.160 |
Why?
| | Cytokines | 5 | 2015 | 2081 | 0.160 |
Why?
| | Metabolic Diseases | 1 | 2021 | 114 | 0.160 |
Why?
| | Phenylephrine | 3 | 2008 | 74 | 0.160 |
Why?
| | Vasodilator Agents | 2 | 2013 | 326 | 0.160 |
Why?
| | Hormones | 1 | 2021 | 134 | 0.160 |
Why?
| | Receptors, Androgen | 1 | 2021 | 149 | 0.150 |
Why?
| | Body Weight | 2 | 2015 | 968 | 0.150 |
Why?
| | Testosterone | 4 | 2014 | 419 | 0.150 |
Why?
| | Models, Cardiovascular | 1 | 2021 | 194 | 0.150 |
Why?
| | Phenotype | 2 | 2026 | 3206 | 0.150 |
Why?
| | National Heart, Lung, and Blood Institute (U.S.) | 4 | 2022 | 103 | 0.150 |
Why?
| | Practice Guidelines as Topic | 2 | 2018 | 1591 | 0.150 |
Why?
| | Drugs, Investigational | 1 | 2019 | 31 | 0.150 |
Why?
| | Ovariectomy | 4 | 2015 | 164 | 0.150 |
Why?
| | Receptors, G-Protein-Coupled | 1 | 2021 | 233 | 0.150 |
Why?
| | Organ Size | 1 | 2020 | 465 | 0.150 |
Why?
| | Education, Medical, Graduate | 1 | 2024 | 568 | 0.150 |
Why?
| | Inflammation | 3 | 2024 | 2919 | 0.150 |
Why?
| | Vasoconstrictor Agents | 3 | 2008 | 148 | 0.150 |
Why?
| | Young Adult | 8 | 2021 | 14330 | 0.150 |
Why?
| | Mice, Knockout | 4 | 2021 | 3125 | 0.140 |
Why?
| | HLA-DP alpha-Chains | 1 | 2018 | 4 | 0.140 |
Why?
| | Mesenchymal Stem Cell Transplantation | 3 | 2008 | 63 | 0.140 |
Why?
| | Cardiac Catheterization | 2 | 2020 | 571 | 0.140 |
Why?
| | Muscle, Skeletal | 3 | 2025 | 1818 | 0.140 |
Why?
| | Y Chromosome | 1 | 2018 | 37 | 0.140 |
Why?
| | Gender Identity | 1 | 2019 | 132 | 0.140 |
Why?
| | RNA, Long Noncoding | 1 | 2021 | 174 | 0.140 |
Why?
| | Lipopolysaccharides | 4 | 2010 | 861 | 0.140 |
Why?
| | Troponin T | 1 | 2019 | 63 | 0.140 |
Why?
| | Respiratory Mucosa | 1 | 2021 | 323 | 0.140 |
Why?
| | Hypoxia-Inducible Factor-Proline Dioxygenases | 1 | 2018 | 21 | 0.140 |
Why?
| | Nitric Oxide Synthase Type III | 2 | 2016 | 199 | 0.140 |
Why?
| | Procollagen-Proline Dioxygenase | 1 | 2018 | 27 | 0.140 |
Why?
| | Risk Factors | 3 | 2026 | 10921 | 0.140 |
Why?
| | Animals, Newborn | 4 | 2015 | 888 | 0.140 |
Why?
| | Cyclic Nucleotide Phosphodiesterases, Type 5 | 1 | 2018 | 23 | 0.140 |
Why?
| | Arterial Pressure | 2 | 2016 | 130 | 0.140 |
Why?
| | Propensity Score | 1 | 2020 | 376 | 0.140 |
Why?
| | Adult Stem Cells | 2 | 2008 | 39 | 0.140 |
Why?
| | HLA-DP beta-Chains | 1 | 2018 | 88 | 0.140 |
Why?
| | Oxygen Consumption | 2 | 2024 | 721 | 0.140 |
Why?
| | p38 Mitogen-Activated Protein Kinases | 2 | 2017 | 263 | 0.130 |
Why?
| | RNA, Messenger | 4 | 2021 | 2791 | 0.130 |
Why?
| | Metabolome | 1 | 2021 | 390 | 0.130 |
Why?
| | Isolated Heart Preparation | 1 | 2017 | 6 | 0.130 |
Why?
| | Bronchoscopy | 3 | 2021 | 227 | 0.130 |
Why?
| | bcl-2-Associated X Protein | 1 | 2017 | 53 | 0.130 |
Why?
| | Protein Stability | 1 | 2018 | 180 | 0.130 |
Why?
| | Cardiac Output | 3 | 2015 | 176 | 0.130 |
Why?
| | Risk Assessment | 4 | 2023 | 3712 | 0.130 |
Why?
| | Mutation | 2 | 2026 | 4093 | 0.130 |
Why?
| | Peptide Fragments | 2 | 2019 | 693 | 0.130 |
Why?
| | Diastole | 1 | 2017 | 147 | 0.130 |
Why?
| | CD55 Antigens | 1 | 2016 | 31 | 0.120 |
Why?
| | Dietary Supplements | 1 | 2021 | 587 | 0.120 |
Why?
| | Myocardial Infarction | 2 | 2019 | 1215 | 0.120 |
Why?
| | Pyrroles | 1 | 2017 | 222 | 0.120 |
Why?
| | Computed Tomography Angiography | 1 | 2017 | 151 | 0.120 |
Why?
| | Proto-Oncogene Proteins c-bcl-2 | 1 | 2017 | 237 | 0.120 |
Why?
| | Women's Health | 1 | 2018 | 317 | 0.120 |
Why?
| | Metabolic Syndrome | 1 | 2020 | 364 | 0.120 |
Why?
| | Epithelium | 1 | 2016 | 295 | 0.110 |
Why?
| | Personnel Selection | 1 | 2017 | 90 | 0.110 |
Why?
| | Dyspnea | 1 | 2017 | 251 | 0.110 |
Why?
| | Ventricular Dysfunction, Left | 1 | 2019 | 391 | 0.110 |
Why?
| | Research Report | 1 | 2016 | 89 | 0.110 |
Why?
| | Melanocytes | 1 | 2015 | 57 | 0.110 |
Why?
| | Golgi Apparatus | 1 | 2015 | 99 | 0.110 |
Why?
| | Biological Assay | 1 | 2016 | 133 | 0.110 |
Why?
| | Telemetry | 1 | 2015 | 41 | 0.110 |
Why?
| | Physical Exertion | 1 | 2016 | 204 | 0.110 |
Why?
| | Stem Cells | 3 | 2008 | 613 | 0.110 |
Why?
| | Genetic Testing | 1 | 2018 | 492 | 0.110 |
Why?
| | Mice, Inbred C57BL | 9 | 2025 | 6034 | 0.110 |
Why?
| | Physical Endurance | 1 | 2016 | 278 | 0.110 |
Why?
| | Pulmonary Blastoma | 1 | 2014 | 8 | 0.110 |
Why?
| | Blood Pressure Monitoring, Ambulatory | 1 | 2015 | 69 | 0.110 |
Why?
| | Health Services Accessibility | 1 | 2023 | 1107 | 0.110 |
Why?
| | Models, Biological | 6 | 2021 | 1761 | 0.100 |
Why?
| | Sleep Wake Disorders | 1 | 2018 | 314 | 0.100 |
Why?
| | Macrophages | 1 | 2022 | 1532 | 0.100 |
Why?
| | Health Policy | 1 | 2017 | 399 | 0.100 |
Why?
| | Familial Hypophosphatemic Rickets | 1 | 2014 | 6 | 0.100 |
Why?
| | Dehydroepiandrosterone | 1 | 2014 | 50 | 0.100 |
Why?
| | Chest Pain | 1 | 2014 | 100 | 0.100 |
Why?
| | Combined Modality Therapy | 1 | 2017 | 1271 | 0.100 |
Why?
| | Indoles | 1 | 2017 | 511 | 0.100 |
Why?
| | Splenectomy | 1 | 2013 | 61 | 0.100 |
Why?
| | Transcriptome | 1 | 2020 | 1068 | 0.100 |
Why?
| | Treatment Outcome | 3 | 2016 | 11821 | 0.100 |
Why?
| | World Health Organization | 1 | 2013 | 104 | 0.100 |
Why?
| | Ovary | 1 | 2015 | 236 | 0.090 |
Why?
| | Phosphates | 1 | 2014 | 175 | 0.090 |
Why?
| | Pulmonary Alveoli | 1 | 2015 | 385 | 0.090 |
Why?
| | Fever | 1 | 2014 | 322 | 0.090 |
Why?
| | Diagnosis, Differential | 2 | 2014 | 1503 | 0.090 |
Why?
| | Precision Medicine | 1 | 2017 | 462 | 0.090 |
Why?
| | Pulmonary Veins | 1 | 2014 | 110 | 0.090 |
Why?
| | Fibroblast Growth Factors | 1 | 2014 | 187 | 0.090 |
Why?
| | Oxygen | 2 | 2015 | 997 | 0.090 |
Why?
| | Ischemia | 3 | 2015 | 421 | 0.090 |
Why?
| | Dose-Response Relationship, Drug | 4 | 2011 | 2022 | 0.090 |
Why?
| | Asthma | 2 | 2021 | 1800 | 0.090 |
Why?
| | Myocardial Ischemia | 3 | 2008 | 286 | 0.090 |
Why?
| | Estrogen Antagonists | 1 | 2012 | 37 | 0.090 |
Why?
| | Cyclin-Dependent Kinase Inhibitor p27 | 1 | 2012 | 64 | 0.090 |
Why?
| | Mutation, Missense | 1 | 2014 | 334 | 0.090 |
Why?
| | ROC Curve | 1 | 2014 | 617 | 0.090 |
Why?
| | Cardiopulmonary Resuscitation | 1 | 2015 | 334 | 0.090 |
Why?
| | Exercise | 1 | 2024 | 2213 | 0.090 |
Why?
| | Airway Remodeling | 1 | 2012 | 63 | 0.090 |
Why?
| | Myocardial Perfusion Imaging | 1 | 2011 | 50 | 0.090 |
Why?
| | Models, Animal | 2 | 2010 | 387 | 0.080 |
Why?
| | Length of Stay | 1 | 2017 | 1358 | 0.080 |
Why?
| | Heart Arrest | 1 | 2015 | 411 | 0.080 |
Why?
| | Oxidoreductases | 1 | 2011 | 91 | 0.080 |
Why?
| | Tumor Necrosis Factor-alpha | 4 | 2008 | 1224 | 0.080 |
Why?
| | Ceramides | 1 | 2011 | 114 | 0.080 |
Why?
| | Healthcare Disparities | 1 | 2017 | 733 | 0.080 |
Why?
| | Endothelium, Vascular | 2 | 2007 | 952 | 0.080 |
Why?
| | Exercise Test | 2 | 2024 | 637 | 0.080 |
Why?
| | Acute Disease | 2 | 2010 | 1038 | 0.080 |
Why?
| | Exercise Therapy | 1 | 2015 | 488 | 0.080 |
Why?
| | Retrospective Studies | 4 | 2017 | 17438 | 0.080 |
Why?
| | Immunomodulation | 1 | 2010 | 98 | 0.070 |
Why?
| | Gene Expression Regulation, Neoplastic | 1 | 2015 | 1432 | 0.070 |
Why?
| | Angiopoietin-1 | 1 | 2009 | 12 | 0.070 |
Why?
| | Cardiovascular Diseases | 1 | 2021 | 2219 | 0.070 |
Why?
| | Immune System | 1 | 2010 | 181 | 0.070 |
Why?
| | Rabbits | 1 | 2010 | 651 | 0.070 |
Why?
| | Propofol | 1 | 2009 | 86 | 0.070 |
Why?
| | Radiography | 1 | 2011 | 861 | 0.070 |
Why?
| | NG-Nitroarginine Methyl Ester | 1 | 2008 | 48 | 0.070 |
Why?
| | Prognosis | 1 | 2017 | 4351 | 0.070 |
Why?
| | Nitric Oxide Synthase Type I | 1 | 2008 | 31 | 0.070 |
Why?
| | Receptors, Tumor Necrosis Factor, Type II | 1 | 2008 | 41 | 0.070 |
Why?
| | Receptors, Tumor Necrosis Factor, Type I | 1 | 2008 | 79 | 0.070 |
Why?
| | Coronary Artery Bypass | 1 | 2010 | 269 | 0.070 |
Why?
| | Vasodilation | 1 | 2011 | 519 | 0.070 |
Why?
| | Colorado | 1 | 2018 | 4595 | 0.070 |
Why?
| | Phenols | 1 | 2008 | 106 | 0.070 |
Why?
| | Embryonic Stem Cells | 1 | 2008 | 124 | 0.070 |
Why?
| | Ventricular Function | 1 | 2007 | 53 | 0.070 |
Why?
| | Pluripotent Stem Cells | 1 | 2008 | 78 | 0.070 |
Why?
| | JNK Mitogen-Activated Protein Kinases | 1 | 2008 | 153 | 0.060 |
Why?
| | Education | 2 | 2018 | 103 | 0.060 |
Why?
| | Pyruvates | 1 | 2007 | 23 | 0.060 |
Why?
| | Acute Kidney Injury | 1 | 2015 | 866 | 0.060 |
Why?
| | Steroids | 1 | 2008 | 160 | 0.060 |
Why?
| | Adrenergic beta-Antagonists | 1 | 2009 | 253 | 0.060 |
Why?
| | Hypnotics and Sedatives | 1 | 2009 | 223 | 0.060 |
Why?
| | Nurses | 1 | 2009 | 171 | 0.060 |
Why?
| | Dihydrotestosterone | 1 | 2007 | 40 | 0.060 |
Why?
| | Positive-Pressure Respiration | 1 | 2008 | 115 | 0.060 |
Why?
| | Antifungal Agents | 1 | 2008 | 153 | 0.060 |
Why?
| | Fibrosis | 2 | 2020 | 568 | 0.060 |
Why?
| | Deferoxamine | 1 | 2007 | 27 | 0.060 |
Why?
| | Iron Chelating Agents | 1 | 2007 | 17 | 0.060 |
Why?
| | Carbon Dioxide | 1 | 2008 | 228 | 0.060 |
Why?
| | Potassium Channels, Voltage-Gated | 1 | 2007 | 54 | 0.060 |
Why?
| | Bone Marrow Transplantation | 1 | 2008 | 301 | 0.060 |
Why?
| | rho-Associated Kinases | 1 | 2007 | 77 | 0.060 |
Why?
| | Amino Acids, Dicarboxylic | 2 | 2016 | 9 | 0.060 |
Why?
| | Emphysema | 1 | 2007 | 100 | 0.060 |
Why?
| | Homeostasis | 1 | 2010 | 646 | 0.060 |
Why?
| | Gastrointestinal Diseases | 1 | 2008 | 220 | 0.060 |
Why?
| | Epithelial Cells | 2 | 2016 | 1119 | 0.060 |
Why?
| | Internship and Residency | 1 | 2017 | 1281 | 0.060 |
Why?
| | Interleukin-6 | 2 | 2008 | 784 | 0.060 |
Why?
| | Anesthesia | 1 | 2009 | 257 | 0.060 |
Why?
| | Androgens | 1 | 2007 | 179 | 0.060 |
Why?
| | RNA Editing | 1 | 2025 | 26 | 0.060 |
Why?
| | Endothelin-1 | 1 | 2007 | 177 | 0.060 |
Why?
| | Research Design | 2 | 2025 | 1143 | 0.060 |
Why?
| | Gene Expression | 2 | 2021 | 1463 | 0.060 |
Why?
| | Coronary Disease | 1 | 2008 | 380 | 0.060 |
Why?
| | Inflammation Mediators | 1 | 2008 | 508 | 0.060 |
Why?
| | Beta vulgaris | 1 | 2025 | 15 | 0.060 |
Why?
| | Cyclic GMP | 1 | 2025 | 88 | 0.060 |
Why?
| | Hospitalization | 1 | 2016 | 2475 | 0.060 |
Why?
| | Body Mass Index | 1 | 2014 | 2458 | 0.050 |
Why?
| | Enzyme Inhibitors | 1 | 2008 | 823 | 0.050 |
Why?
| | Prospective Studies | 1 | 2017 | 8123 | 0.050 |
Why?
| | MAP Kinase Signaling System | 1 | 2007 | 307 | 0.050 |
Why?
| | Pyrazoles | 1 | 2008 | 517 | 0.050 |
Why?
| | Muscle, Smooth, Vascular | 1 | 2007 | 449 | 0.050 |
Why?
| | Embolectomy | 1 | 2023 | 13 | 0.050 |
Why?
| | NF-kappa B | 1 | 2008 | 674 | 0.050 |
Why?
| | Anti-Inflammatory Agents | 1 | 2007 | 474 | 0.050 |
Why?
| | Orchiectomy | 3 | 2008 | 72 | 0.050 |
Why?
| | Genetic Variation | 2 | 2018 | 996 | 0.050 |
Why?
| | HMGB Proteins | 1 | 2023 | 16 | 0.050 |
Why?
| | Regional Blood Flow | 1 | 2025 | 507 | 0.050 |
Why?
| | Thrombolytic Therapy | 1 | 2023 | 165 | 0.050 |
Why?
| | Lactates | 1 | 2022 | 82 | 0.050 |
Why?
| | Thorax | 1 | 2022 | 51 | 0.050 |
Why?
| | Mechanotransduction, Cellular | 1 | 2023 | 121 | 0.040 |
Why?
| | Bronchopulmonary Dysplasia | 1 | 2007 | 427 | 0.040 |
Why?
| | Infant, Newborn | 2 | 2017 | 6460 | 0.040 |
Why?
| | Breath Tests | 1 | 2021 | 77 | 0.040 |
Why?
| | Nitric Oxide Synthase Type II | 1 | 2021 | 162 | 0.040 |
Why?
| | Intestinal Mucosa | 1 | 2007 | 666 | 0.040 |
Why?
| | Fibrillar Collagens | 1 | 2020 | 15 | 0.040 |
Why?
| | Kallikreins | 1 | 2020 | 25 | 0.040 |
Why?
| | Aging | 2 | 2008 | 1996 | 0.040 |
Why?
| | Proto-Oncogene Proteins c-jun | 1 | 2020 | 51 | 0.040 |
Why?
| | Rats, Wistar | 1 | 2022 | 451 | 0.040 |
Why?
| | Cattle | 1 | 2023 | 940 | 0.040 |
Why?
| | Incidental Findings | 1 | 2021 | 81 | 0.040 |
Why?
| | Mice, Transgenic | 1 | 2025 | 2134 | 0.040 |
Why?
| | Enzyme Activation | 2 | 2015 | 759 | 0.040 |
Why?
| | Vital Capacity | 1 | 2021 | 293 | 0.040 |
Why?
| | Down-Regulation | 2 | 2016 | 614 | 0.040 |
Why?
| | Kinetics | 2 | 2015 | 1553 | 0.040 |
Why?
| | Forced Expiratory Volume | 1 | 2021 | 451 | 0.040 |
Why?
| | Biological Specimen Banks | 1 | 2021 | 137 | 0.040 |
Why?
| | United Kingdom | 1 | 2021 | 377 | 0.040 |
Why?
| | Mitochondria, Heart | 1 | 2020 | 107 | 0.040 |
Why?
| | Ligands | 1 | 2021 | 678 | 0.040 |
Why?
| | NAD | 1 | 2020 | 80 | 0.040 |
Why?
| | Genotyping Techniques | 1 | 2018 | 74 | 0.030 |
Why?
| | Cell Shape | 2 | 2008 | 56 | 0.030 |
Why?
| | Behavior | 1 | 2018 | 90 | 0.030 |
Why?
| | Gene Expression Regulation | 1 | 2007 | 2599 | 0.030 |
Why?
| | Hepatocyte Growth Factor | 2 | 2008 | 33 | 0.030 |
Why?
| | Cohort Studies | 2 | 2021 | 6077 | 0.030 |
Why?
| | RNA, Small Interfering | 2 | 2011 | 633 | 0.030 |
Why?
| | National Institutes of Health (U.S.) | 1 | 2018 | 147 | 0.030 |
Why?
| | Critical Care | 1 | 2023 | 706 | 0.030 |
Why?
| | Curriculum | 1 | 2024 | 1079 | 0.030 |
Why?
| | Intensive Care Units | 1 | 2023 | 925 | 0.030 |
Why?
| | Sleep Apnea Syndromes | 1 | 2018 | 98 | 0.030 |
Why?
| | Job Application | 1 | 2017 | 17 | 0.030 |
Why?
| | Comprehension | 1 | 2018 | 175 | 0.030 |
Why?
| | Congresses as Topic | 1 | 2018 | 226 | 0.030 |
Why?
| | Extracellular Signal-Regulated MAP Kinases | 2 | 2008 | 174 | 0.030 |
Why?
| | Clinical Competence | 1 | 2024 | 1272 | 0.030 |
Why?
| | Biomechanical Phenomena | 1 | 2020 | 874 | 0.030 |
Why?
| | Proteomics | 1 | 2023 | 1203 | 0.030 |
Why?
| | Prolyl Hydroxylases | 1 | 2015 | 6 | 0.030 |
Why?
| | Gene Silencing | 1 | 2016 | 200 | 0.030 |
Why?
| | Insulin-Like Growth Factor I | 2 | 2008 | 320 | 0.030 |
Why?
| | Blood Urea Nitrogen | 1 | 2015 | 53 | 0.030 |
Why?
| | Prolyl-Hydroxylase Inhibitors | 1 | 2015 | 6 | 0.030 |
Why?
| | Cyclopentanes | 1 | 2015 | 17 | 0.030 |
Why?
| | Adolescent | 4 | 2021 | 22557 | 0.030 |
Why?
| | Pulmonary Gas Exchange | 1 | 2015 | 117 | 0.030 |
Why?
| | Cell Line, Tumor | 2 | 2015 | 3545 | 0.030 |
Why?
| | Chloroquine | 1 | 2015 | 54 | 0.030 |
Why?
| | Renal Circulation | 1 | 2015 | 75 | 0.030 |
Why?
| | Enzyme-Linked Immunosorbent Assay | 2 | 2008 | 846 | 0.030 |
Why?
| | Lysosomes | 1 | 2015 | 134 | 0.030 |
Why?
| | Age Factors | 2 | 2015 | 3347 | 0.030 |
Why?
| | Proteolysis | 1 | 2015 | 174 | 0.030 |
Why?
| | Proteasome Endopeptidase Complex | 1 | 2015 | 155 | 0.030 |
Why?
| | Disease Management | 1 | 2018 | 651 | 0.030 |
Why?
| | Steroid Hydroxylases | 1 | 2014 | 20 | 0.030 |
Why?
| | Vitamin D3 24-Hydroxylase | 1 | 2014 | 16 | 0.030 |
Why?
| | Protein Folding | 1 | 2015 | 281 | 0.030 |
Why?
| | Protein Transport | 1 | 2015 | 443 | 0.030 |
Why?
| | Gene Knock-In Techniques | 1 | 2014 | 60 | 0.030 |
Why?
| | Calcitriol | 1 | 2014 | 59 | 0.020 |
Why?
| | Creatinine | 1 | 2015 | 511 | 0.020 |
Why?
| | Mice, Mutant Strains | 1 | 2014 | 290 | 0.020 |
Why?
| | Complement Activation | 1 | 2016 | 412 | 0.020 |
Why?
| | Radiography, Thoracic | 1 | 2014 | 174 | 0.020 |
Why?
| | Glycolysis | 1 | 2015 | 342 | 0.020 |
Why?
| | Mortality | 1 | 2016 | 375 | 0.020 |
Why?
| | Endoplasmic Reticulum | 1 | 2015 | 268 | 0.020 |
Why?
| | Amino Acid Substitution | 1 | 2014 | 297 | 0.020 |
Why?
| | Phosphorylation | 2 | 2008 | 1724 | 0.020 |
Why?
| | Cell Nucleus | 1 | 2015 | 584 | 0.020 |
Why?
| | Pyrimidines | 1 | 2015 | 532 | 0.020 |
Why?
| | Genome-Wide Association Study | 1 | 2018 | 1537 | 0.020 |
Why?
| | Computer Simulation | 1 | 2016 | 1014 | 0.020 |
Why?
| | Polymorphism, Single Nucleotide | 1 | 2018 | 2240 | 0.020 |
Why?
| | Pulmonary Disease, Chronic Obstructive | 1 | 2018 | 928 | 0.020 |
Why?
| | Protein Kinase Inhibitors | 2 | 2008 | 983 | 0.020 |
Why?
| | Severity of Illness Index | 1 | 2018 | 2921 | 0.020 |
Why?
| | Genetic Predisposition to Disease | 1 | 2018 | 2488 | 0.020 |
Why?
| | Biosensing Techniques | 1 | 2011 | 143 | 0.020 |
Why?
| | Predictive Value of Tests | 1 | 2015 | 2113 | 0.020 |
Why?
| | Infant | 2 | 2017 | 10114 | 0.020 |
Why?
| | Transcription, Genetic | 1 | 2015 | 1432 | 0.020 |
Why?
| | Propanolamines | 1 | 2009 | 40 | 0.020 |
Why?
| | Quality of Life | 1 | 2021 | 3200 | 0.020 |
Why?
| | Short Bowel Syndrome | 1 | 2008 | 24 | 0.020 |
Why?
| | Enterocolitis, Necrotizing | 1 | 2008 | 39 | 0.020 |
Why?
| | Child, Preschool | 2 | 2017 | 11913 | 0.020 |
Why?
| | Mass Spectrometry | 1 | 2011 | 729 | 0.020 |
Why?
| | Endotoxins | 1 | 2009 | 215 | 0.020 |
Why?
| | Organ Specificity | 1 | 2008 | 307 | 0.020 |
Why?
| | Tissue and Organ Harvesting | 1 | 2008 | 69 | 0.020 |
Why?
| | Stromal Cells | 1 | 2008 | 123 | 0.020 |
Why?
| | Fibroblast Growth Factor 2 | 1 | 2008 | 93 | 0.020 |
Why?
| | Osteoblasts | 1 | 2008 | 145 | 0.020 |
Why?
| | Culture Media, Conditioned | 1 | 2007 | 112 | 0.020 |
Why?
| | Organ Culture Techniques | 1 | 2007 | 150 | 0.020 |
Why?
| | MAP Kinase Kinase 4 | 1 | 2007 | 24 | 0.020 |
Why?
| | RNA Interference | 1 | 2008 | 472 | 0.020 |
Why?
| | Cell Lineage | 1 | 2008 | 377 | 0.020 |
Why?
| | Tibia | 1 | 2008 | 177 | 0.020 |
Why?
| | Adipocytes | 1 | 2008 | 223 | 0.020 |
Why?
| | In Vitro Techniques | 1 | 2008 | 1041 | 0.010 |
Why?
| | Transfection | 1 | 2008 | 916 | 0.010 |
Why?
| | Administration, Oral | 1 | 2009 | 872 | 0.010 |
Why?
| | Femur | 1 | 2008 | 264 | 0.010 |
Why?
| | Diet | 1 | 2014 | 1273 | 0.010 |
Why?
| | Thoracic Surgery | 1 | 2007 | 145 | 0.010 |
Why?
| | Analysis of Variance | 1 | 2008 | 1298 | 0.010 |
Why?
| | Feasibility Studies | 1 | 2009 | 1135 | 0.010 |
Why?
| | Blotting, Western | 1 | 2007 | 1177 | 0.010 |
Why?
| | Tissue Engineering | 1 | 2008 | 442 | 0.010 |
Why?
| | Heart Diseases | 1 | 2007 | 343 | 0.010 |
Why?
| | Inflammatory Bowel Diseases | 1 | 2008 | 352 | 0.010 |
Why?
| | Tomography, X-Ray Computed | 1 | 2014 | 2786 | 0.010 |
Why?
| | Cell Proliferation | 1 | 2011 | 2502 | 0.010 |
Why?
| | Child | 2 | 2017 | 22693 | 0.010 |
Why?
| | Glucose | 1 | 2009 | 1053 | 0.010 |
Why?
| | Interleukin-1 | 1 | 2007 | 960 | 0.010 |
Why?
| | Fibroblasts | 1 | 2008 | 1034 | 0.010 |
Why?
| | Fetus | 1 | 2007 | 800 | 0.010 |
Why?
| | Cell Line | 1 | 2007 | 2814 | 0.010 |
Why?
| | Pregnancy | 1 | 2014 | 7230 | 0.010 |
Why?
| | Cell Differentiation | 1 | 2008 | 1982 | 0.010 |
Why?
| | Neurons | 1 | 2008 | 1668 | 0.010 |
Why?
| | Time Factors | 1 | 2008 | 7109 | 0.010 |
Why?
|
|
Lahm's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors  People in Profiles who have published with this person. _
Similar People  People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
|